New study conducted by USCF maps the links between 625 genes and various different chemotherapy treatments

Despite successes of targeted cancer drugs and the promise of novel immunotherapies, the vast majority of people diagnosed with cancer are treated with chemotherapy. Now a new study by UCSF researchers using techniques drawn from computational biology could make it easier for physicians to use the patient’s genetic profile of the tumour to pick the

Continue Reading

Research team at Vanderbilt University discover ionising radiation can soften tumour cell microenvironment

Approximately half of all cancer patients receive radiation therapy to reduce the growth of malignant cells. However, little is known about how ionising radiation affects the extracellular matrix (ECM), a patchwork of proteins and other biomolecules that surrounds cells and plays a vital role in their shape, movement and signalling functions. A team of researchers

Continue Reading

Portorn Biopharm aims to manufacture new class of IBD medication using gut bacteria spores

Chain Biotechnology company, Porton Biopharma and Scitech have acquired grant funding from Innovate UK to investigate the manufacture of a new class of medicines that target a range of clinical conditions such as ulcerative colitis and Chrohn’s disease through interaction with the human microbiome Three leading British biotechnologies have obtained grant funding from Innovate UK

Continue Reading

3-D printed models created by Stanford School of Medicine that will improve medical student training

According to a study presented at the Society of Interventional Radiology’s 2018 Annual Scientific Meeting , an inexpensive 3-D-printed model of a patient’s blood vessels is as effective as current commercially available models for training medical students in interventional radiology vascular access. “We’ve come up with a viable method for creating something that’s inexpensive and

Continue Reading

UK based developer gains investment for world’s first portable fingerprint drug test

UK-based Intelligent Fingerprinting, have secured £1.7 million of funding from a group of private US and UK investors for the world’s first portable fingerprint drug test. The investment will allow for accelerated commercialisation of the recently launched Intelligent Fingerprinting Drug Screening System. Particularly into key UK workplace market sectors such as construction, transport, warehousing and

Continue Reading

Gene therapy medication, Spinraza, provides improvements for patients with spinal muscular atrophy

Spinraza has provided significant improvements in cases with the next most severe form of the neuromuscular disease, spinal muscular atrophy (SMA), which affects children aged from 6 to 18 months.   “The effects are convincing, and this reinforces results from the earlier study,” says Mar Tulinius, Professor of paediatrics at Sahlgrenska Academy and chief medical

Continue Reading

Bicycle and CRUK to launch first clinical trial of bicyclic peptide for use in treating tumours

Bicycle Therapeutics and Cancer Research UK have commenced the first clinical study to assess a bicyclic peptide to evaluate its potential in patients with advanced solid tumours. The first patient has now been dosed in a Phase I/IIa trial with BT1718, a first-in-class Bicycle Toxin Conjugate that targets Membrane Type 1 Matrix Metalloproteinase, which is

Continue Reading